Keywords: Ligand, Merck & Co, Organon, Schering-Plugh, Research

Ligand earns $2 million in milestone from Merck & Co via previous Organon deal

Article | 20 November 2009

Print This

US developer Ligand Pharmaceuticals says it has received $2 million in milestone payments from Organon, a subsidiary of Merck & Co, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in